2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))

C134H106B5N17O10Pt5 — CID 160931031

IUPAC2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))
SMILESCC(C)c1cccc(C(C)C)c1-c1cnn(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)c1.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5cccnc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5ccncc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)Oc2ccccc21.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C34H32BN3O2.2C27H19BN4O2.C24H20BN3O2.C22H16BN3O2.5Pt/c1-23(2)30-15-10-16-31(24(3)4)34(30)25-21-36-38(22-25)27-12-9-14-29(20-27)39-28-13-8-11-26(19-28)35-37(5)32-17-6-7-18-33(32)40-35;1-31-26-12-2-3-13-27(26)34-28(31)22-8-4-10-24(15-22)33-25-11-5-9-23(16-25)32-19-21(18-30-32)20-7-6-14-29-17-20;1-31-26-10-2-3-11-27(26)34-28(31)22-6-4-8-24(16-22)33-25-9-5-7-23(17-25)32-19-21(18-30-32)20-12-14-29-15-13-20;1-17-14-18(2)28(26-17)20-9-7-11-22(16-20)29-21-10-6-8-19(15-21)25-27(3)23-12-4-5-13-24(23)30-25;1-25-21-11-2-3-12-22(21)28-23(25)17-7-4-9-19(15-17)27-20-10-5-8-18(16-20)26-14-6-13-24-26;;;;;/h6-18,21-24H,1-5H3;2-14,17-19H,1H3;2-15,18-19H,1H3;4-14H,1-3H3;2-14H,1H3;;;;;/q5*-2;5*+2
InChIKeyNYFXYVJRCYATLN-UHFFFAOYSA-N
MW3143.88 g/mol
LogP24.09
Rot. Bonds25

About 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))

2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) (PubChem CID 160931031) has the molecular formula C134H106B5N17O10Pt5 and a molecular weight of 3143.88 g/mol. Its IUPAC name is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)).

Molecular Properties

Compound Name2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))
PubChem CID160931031
Molecular FormulaC134H106B5N17O10Pt5
Molecular Weight3143.88 g/mol
Exact Mass3142.70
IUPAC Name2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))
SMILESCC(C)c1cccc(C(C)C)c1-c1cnn(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)c1.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5cccnc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5ccncc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)Oc2ccccc21.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C34H32BN3O2.2C27H19BN4O2.C24H20BN3O2.C22H16BN3O2.5Pt/c1-23(2)30-15-10-16-31(24(3)4)34(30)25-21-36-38(22-25)27-12-9-14-29(20-27)39-28-13-8-11-26(19-28)35-37(5)32-17-6-7-18-33(32)40-35;1-31-26-12-2-3-13-27(26)34-28(31)22-8-4-10-24(15-22)33-25-11-5-9-23(16-25)32-19-21(18-30-32)20-7-6-14-29-17-20;1-31-26-10-2-3-11-27(26)34-28(31)22-6-4-8-24(16-22)33-25-9-5-7-23(17-25)32-19-21(18-30-32)20-12-14-29-15-13-20;1-17-14-18(2)28(26-17)20-9-7-11-22(16-20)29-21-10-6-8-19(15-21)25-27(3)23-12-4-5-13-24(23)30-25;1-25-21-11-2-3-12-22(21)28-23(25)17-7-4-9-19(15-17)27-20-10-5-8-18(16-20)26-14-6-13-24-26;;;;;/h6-18,21-24H,1-5H3;2-14,17-19H,1H3;2-15,18-19H,1H3;4-14H,1-3H3;2-14H,1H3;;;;;/q5*-2;5*+2
InChIKeyNYFXYVJRCYATLN-UHFFFAOYSA-N
XLogP24.09
TPSA223.38 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds25
Heavy Atoms171
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003143.88
LogP ≤ 524.09
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))?
The IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) (CID 160931031) is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)).
What is the SMILES notation for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))?
The canonical SMILES for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) is CC(C)c1cccc(C(C)C)c1-c1cnn(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)c1.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5cccnc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cc(-c5ccncc5)cn4)ccc3)ccc2)Oc2ccccc21.CN1B(c2[c-]c(Oc3[c-]c(-n4cccn4)ccc3)ccc2)Oc2ccccc21.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(B4Oc5ccccc5N4C)ccc3)ccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))?
The InChIKey is NYFXYVJRCYATLN-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H32BN3O2.2C27H19BN4O2.C24H20BN3O2.C22H16BN3O2.5Pt/c1-23(2)30-15-10-16-31(24(3)4)34(30)25-21-36-38(22-25)27-12-9-14-29(20-27)39-28-13-8-11-26(19-28)35-37(5)32-17-6-7-18-33(32)40-35;1-31-26-12-2-3-13-27(26)34-28(31)22-8-4-10-24(15-22)33-25-11-5-9-23(16-25)32-19-21(18-30-32)20-7-6-14-29-17-20;1-31-26-10-2-3-11-27(26)34-28(31)22-6-4-8-24(16-22)33-25-9-5-7-23(17-25)32-19-21(18-30-32)20-12-14-29-15-13-20;1-17-14-18(2)28(26-17)20-9-7-11-22(16-20)29-21-10-6-8-19(15-21)25-27(3)23-12-4-5-13-24(23)30-25;1-25-21-11-2-3-12-22(21)28-23(25)17-7-4-9-19(15-17)27-20-10-5-8-18(16-20)26-14-6-13-24-26;;;;;/h6-18,21-24H,1-5H3;2-14,17-19H,1H3;2-15,18-19H,1H3;4-14H,1-3H3;2-14H,1H3;;;;;/q5*-2;5*+2.
What are the key properties of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+))?
2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) has a molecular weight of 3143.88 g/mol, XLogP of 24.09, 25 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;2-[3-[3-[4-[2,6-di(propan-2-yl)phenyl]pyrazol-1-yl]benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-methyl-1,3,2-benzoxazaborole;3-methyl-2-[3-(3-pyrazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-3-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;3-methyl-2-[3-[3-(4-pyridin-4-ylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-1,3,2-benzoxazaborole;pentakis(platinum(2+)) is sourced from PubChem (CID 160931031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).